NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Updates, CAR T-Cell therapy, BTK Inhibitors, Bispecific T-Cell Engagers, and More SAN…
Latest Blood Cancer Treatment Updates Presented at Annual NCCN Event During Blood Cancer Awareness Month
This post was originally published on this site